Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2002 Nov 26;59(10):1625-7.

SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.

Author information

1
Movement Disorder Clinic, Department of Clinical Neurosciences, University of Calgary, Alberta, Canada.

Abstract

The authors describe an Alberta family with levodopa-responsive parkinsonism without cerebellar abnormalities. Genetic testing showed expanded repeats for SCA-2; other mutations for parkinsonism were excluded. The expanded allele shows interruption of the CAG repeat with CAA. PET in two affected members showed reduced fluorodopa uptake in striatum and normal raclopride binding. Families with autosomal dominant, levodopa-responsive parkinsonism should be tested for the SCA-2 mutation.

PMID:
12451209
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center